Trial · NCT03011450
Results by group228
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 228
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in Fasting TG From Baseline to Week 12 | K-877 | -58.89 | Inter-Quartile Range -71.69 to -38.42 | Percent change | |
| Percent Change in Fasting TG From Baseline to Week 12 | Placebo | -22.94 | Inter-Quartile Range -43.98 to 9.67 | Percent change | |
| Percent Change From Baseline to Week 12 in Remnant Cholesterol | K-877 | -55.51 | Inter-Quartile Range -71.29 to -33.64 | Percent change | |
| Percent Change From Baseline to Week 12 in Remnant Cholesterol | Placebo | -13.29 | Inter-Quartile Range -43.30 to 9.76 | Percent change | |
| Percent Change From Baseline to Week 12 in HDL-C | K-877 | 23.50 | Inter-Quartile Range 5.24 to 45.13 | Percent change | |
| Percent Change From Baseline to Week 12 in HDL-C | Placebo | 7.33 | Inter-Quartile Range -4.00 to 18.79 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo A1 | K-877 | 4.05 | Inter-Quartile Range -5.57 to 14.62 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo A1 | Placebo | 0.00 | Inter-Quartile Range -7.80 to 10.01 | Percent change | |
| Percent Change From Baseline to Week 12 in Non-HDL-C | K-877 | -20.98 | Inter-Quartile Range -34.70 to -4.06 | Percent change | |
| Percent Change From Baseline to Week 12 in Non-HDL-C | Placebo | -3.43 | Inter-Quartile Range -23.66 to 6.75 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol | K-877 | -14.55 | Inter-Quartile Range -25.74 to -1.19 | Percent change | |
| Percent Change From Baseline to Week 12 in Total Cholesterol | Placebo | -2.05 | Inter-Quartile Range -17.59 to 7.37 | Percent change | |
| Percent Change From Baseline to Week 12 in LDL-C | K-877 | 31.49 | Inter-Quartile Range 0.65 to 72.06 | Percent change | |
| Percent Change From Baseline to Week 12 in LDL-C | Placebo | 2.30 | Inter-Quartile Range -14.50 to 23.09 | Percent change | |
| Percent Change From Baseline to Week 12 in FFAs | K-877 | -25.25 | Inter-Quartile Range -48.37 to 3.74 | Percent change | |
| Percent Change From Baseline to Week 12 in FFAs | Placebo | -5.51 | Inter-Quartile Range -32.64 to 28.65 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo A2 | K-877 | 19.34 | Inter-Quartile Range 7.27 to 35.41 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo A2 | Placebo | 0.00 | Inter-Quartile Range -8.09 to 6.38 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo B | K-877 | 0.57 | Inter-Quartile Range -14.90 to 16.66 | Percent change | |
| Percent Change From Baseline to Week 12 in Apo B | Placebo | -1.67 | Inter-Quartile Range -11.71 to 12.54 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03011450/results